Patients with multiple sclerosis (MS) have an altered gut microbiome composition and produce less of a certain fatty acid. This was reported by a team of researchers from Ruhr-Universität Bochum, the MDC and the
ECRC
in Cell. Their findings show that propionic acid might be relevant for MS immunotherapy.